We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Watson Faces Suits Over Trilipix, Rapamune ANDAs

Law360 (April 30, 2010, 3:27 PM EDT) -- Watson Pharmaceuticals Inc. has been hit with two patent infringement suits over abbreviated new drug applications to introduce generic versions of Abbott Laboratories cholesterol treatment Trilipix and Pfizer Inc. organ rejection...
To view the full article, register now.